DEF: SeaStar Medical Seeks Stockholder Approval for Equity Plan Changes and Potential Stock Issuance at 2025 Annual Meeting

SeaStar Medical is holding its 2025 Annual Meeting of Stockholders virtually on July 3, 2025, to vote on key proposals including director elections, equity incentive plan amendments, and a potential stock issuance to Lincoln Park Capital Fund, LLC.

Summary

• SeaStar Medical Holding Corporation will hold its 2025 Annual Meeting of Stockholders virtually on July 3, 2025, at 10:00 a.m. Mountain Time.
• Stockholders of record as of May 5, 2025, are entitled to vote on several proposals.
• Proposal 1 involves the election of two Class III Directors, Eric Schlorff and Kenneth Van Heel, to serve until the 2028 annual meeting.
• Proposal 2 seeks approval for an amendment and restatement of the Company's 2022 Omnibus Equity Incentive Plan to increase the authorized shares of common stock from 570,457 to 2,070,457 and remove the evergreen provision.
• Proposal 3 requests approval for the potential future sale and issuance of shares of common stock to Lincoln Park Capital Fund, LLC, which could result in Lincoln Park owning over 19.99% of the Company's outstanding shares.
• Proposal 4 is to ratify the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
• Proposal 5 seeks approval to adjourn or postpone the Annual Meeting if necessary to permit further solicitation of proxies.
• The Board of Directors recommends voting FOR all proposals.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, presenting information in a neutral tone. The proposals themselves have both positive (potential capital) and negative (potential dilution) aspects, resulting in a moderately positive sentiment.

Positives

• The proposed amendment to the 2022 Omnibus Equity Incentive Plan aims to attract, retain, and motivate employees, directors, and consultants.
• The potential stock issuance to Lincoln Park could provide additional capital for the company.
• Ratification of the independent auditor reinforces corporate governance practices.

Negatives

• The potential stock issuance to Lincoln Park could dilute existing stockholders' equity.
• Increasing the number of authorized shares in the equity incentive plan could also lead to dilution.

Risks

• Failure to obtain stockholder approval for the proposed equity plan amendment and stock issuance could limit the company's financial flexibility.
• The potential stock issuance to Lincoln Park is subject to market conditions and the company's discretion, so there is no guarantee that the full $15.0 million will be realized.
• The company's reliance on equity awards as a key element of compensation could be affected if the equity incentive plan is not approved.

Future Outlook

The company seeks to secure stockholder approval for key proposals that will enable it to maintain financial flexibility, attract and retain talent, and continue its operations.

Industry Context

The document reflects standard corporate governance practices for publicly traded companies, including seeking stockholder approval for significant actions such as equity plan amendments and potential stock issuances.

Stakeholder Impact

• Approval of the proposals could impact shareholders through potential dilution or increased capital.
• Employees and consultants could benefit from the amended equity incentive plan.
• The company's financial stability could be affected by the potential stock issuance to Lincoln Park.

Next Steps

• Stockholders are urged to vote on the proposals before the Annual Meeting on July 3, 2025.
• The company will announce preliminary voting results at the Annual Meeting and report the final results in a Current Report on Form 8-K.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Equity Incentive Plan, Director Election, Lincoln Park Capital, Stock Issuance, Corporate Governance, WithumSmith+Brown, Auditor Ratification